Covenant Behavioral Health, a leading healthcare provider for active-duty personnel, veterans, and their families, has received the inaugural grant from Qbtech’s new QbAccess program. This initiative is designed to offer non-profit healthcare organizations access to Qbtech’s FDA-cleared objective ADHD testing…
ILiAD Biotechnologies, a clinical-stage biotech company focused on preventing and treating diseases caused by Bordetella pertussis and other respiratory pathogens, announced that the U.K. Medicines & Healthcare Products Regulatory Agency (MHRA) has granted its BPZE1 next-generation intranasal pertussis vaccine the…
Henry Schein, Inc. (Nasdaq: HSIC) is showcasing a comprehensive range of dental solutions at the 2024 Greater New York Dental Meeting (GNYDM), taking place at the Henry Schein Dental (#4215) and Henry Schein One (#4022) booths. These solutions are designed…
This giving season, we’re proud to highlight the incredible generosity of our employees who dedicate their time, talents, and financial resources to support and strengthen the communities where we live and work. “At Cardinal Health, we have a strong commitment…
CVS Health® (NYSE: CVS) has announced key leadership changes within its Pharmacy and Consumer Wellness (PCW) division. Len Shankman has been appointed president of PCW, reporting to Prem Shah, group president of CVS Health. Lucille Accetta, RPh, MPH, MBA, has…
CVS Health Corporation (NYSE: CVS) has announced the commencement of cash tender offers for certain outstanding senior notes. These tender offers are being made for two categories of notes: the 4.100% Senior Notes due 2025 and a selection of additional…
UnitedHealth Group (NYSE: UNH) has announced its financial guidance in advance of its annual Investor Conference, which will take place on December 4, starting at 8:00 a.m. ET. The company plans to share its outlook for 2025, highlighting key financial…
Reveal Genomics, a Barcelona-based biotechnology startup focused on revolutionizing precision oncology through biomarker innovation, has partnered with the European Institute of Oncology (IEO) to launch a groundbreaking impact study on HER2DX®, the world’s first specialized genomic test for HER2+ breast…
One-year data from the Nalu COMFORT randomized controlled trial (RCT), published in Regional Anesthesia & Pain Medicine, confirms the long-lasting effectiveness of Nalu’s peripheral nerve stimulation (PNS) technology in providing durable pain relief and significant functional improvement. The findings, which…
Vista, a leader in intelligent MRI acquisition software, has announced two-year clinical results demonstrating that Vista Cardiac enhances workflow efficiency, delivers high-quality and consistent imaging, and helps scale cardiac MRI (CMR) programs, increasing patient access. Dr. Raymond Kwong, Director of…
The American Red Cross’s Cell and Gene Therapy Solutions (CGTS) division, a leading provider of allogeneic cell therapy materials, has selected Accellix, Inc. to supply its automated flow cytometry platform for point-of-need testing. Accellix instruments and assays will be used…
GE HealthCare (Nasdaq: GEHC) has announced the 510(k) submission for CleaRecon DL, a deep learning technology aimed at enhancing the quality of cone-beam computed tomography (CBCT) images. This AI-powered 3D reconstruction technology is designed for use in the interventional suite…